3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Follicular
17
Lymphoma, B-Cell, Marginal Zone
17
Leukemia, Myeloid, Acute
17
Congenital Abnormalities
17
Breast Neoplasms
16
Lymphoma, Mantle-Cell
15
Leukemia
15
Lymphoma, Non-Hodgkin
14
Lymphoma, Large B-Cell, Diffuse
14
Multiple Myeloma
12
Lymphoma, Large-Cell, Immunoblastic
11
Lymphoma
11
Burkitt Lymphoma
11
Blast Crisis
11
Myeloproliferative Disorders
10
Myelodysplastic Syndromes
10
Lymphoma, T-Cell, Cutaneous
10
Leukemia, Myelomonocytic, Chronic
10
Leukemia, Myeloid, Accelerated Phase
10
Sezary Syndrome
9
Mycosis Fungoides
9
Leukemia, Myeloid, Chronic-Phase
9
Waldenstrom Macroglobulinemia
8
Lymphoma, Large-Cell, Anaplastic
8
Hodgkin Disease
8
Primary Myelofibrosis
7
Pdgfra-Associated Chronic Eosinophilic Leukemia
6
Neoplasms, Plasma Cell
6
Interventions
Peripheral Blood Stem Cell Transplantation
9
Cyclophosphamide
9
Biopsy
8
fludarabine phosphate
7
Whole-Body Irradiation
6
Tacrolimus
5
Mycophenolic Acid
5
Epoetin Alfa
5
Colposcopy
5
Celecoxib
5
Busulfan
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Methotrexate
4
Melphalan
4
Cyclosporine
4
Cetuximab
4
Antilymphocyte Serum
4
Polymerase Chain Reaction
3
Imiquimod
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Gene Expression Profiling
3
Etoposide
3
Eflornithine
3
Darbepoetin alfa
3
Carboplatin
3
Aspirin
3
fludarabine
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Precancerous Conditions
×
Flow Cytometry
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled